Skip to main content
. 2019 May 16;11:4549–4556. doi: 10.2147/CMAR.S192646

Table 2.

Relation between patient’s characteristics with ccfDNA (ALU115) and integrity (ALU247/ALU115) in increased prostate volume and normal prostate volume group

Number of patients ccfDNA (ALU115) Median(range) (ng/μL) P-value P-value Integrity (ALU247/ALU115) P-value P-value
PCa 0.001
Prostate volume
<35 g (25 cc) 5 49.09 0.956 0.33 0.368
35g (25 cc)–50g (70 cc) 13 50.59 0.34
≫50 g (70 cc) 12 57.12 0.37
BPH
Prostate volume
<35 g (25 cc) 6 12.15 0.161 0.207 0.14 0.363
35 g (25 cc)–50 g (70 cc) 20 13.06 0.16
≫50 g (70 cc) 14 15.60 0.17
Healthy subject
Prostate volume
<35 g (25 cc) 27
35 g (25 cc)–50 g (70 cc) 3
≫50 g (70 cc) 0

Abbreviations: PCa, prostate cancer; BPH, benign prostate hypertrophy; ccfDNA, circulation cell-free DNA.